Huaren Pharmaceutical Co Ltd represents a commitment to providing high-quality healthcare products and services. With a focus on innovation and research, the company aims to contribute to the wellbeing of society. Their corporate philosophy emphasizes integrity, responsibility, and sustainability. Huaren Pharmaceutical Co Ltd strives to deliver value to its customers through continuous improvement, customer-centricity, and a strong sense of social responsibility.

Huaren Pharmaceutical Co Ltd is primarily present in China, where the company is headquartered. As a leading pharmaceutical company in China, Huaren Pharmaceutical Co Ltd operates nationwide and has a strong presence in various regions across the country. With an extensive network of manufacturing facilities, research centers, and distribution channels, the company serves the local market and contributes to the healthcare sector in China.

Huaren Pharmaceutical Co Ltd has achieved several significant milestones. Over the years, the company has seen impressive growth and expansion in its operations. One of the key milestones is the successful development and launch of innovative pharmaceutical products, positioning them at the forefront of the industry. Additionally, Huaren Pharmaceutical has expanded its market reach, establishing a strong presence both domestically and internationally. With a commitment to research and development, the company has received numerous accolades and recognition for its contributions to the healthcare sector. As a trusted name in the industry, Huaren Pharmaceutical Co Ltd continues to strive for excellence and achieve new milestones in the field of pharmaceuticals.

Huaren Pharmaceutical Co Ltd, a leading pharmaceutical company, has a rich history and impressive background. Established in [year], it has evolved into a renowned player in the industry. Huaren Pharmaceutical Co Ltd primarily focuses on developing, manufacturing, and marketing a wide range of pharmaceutical products. With a commitment to innovation and quality, the company has established itself as a trusted provider of healthcare solutions worldwide. Over the years, Huaren Pharmaceutical Co Ltd has strengthened its research and development capabilities, consistently introducing new and effective medicines. Its dedication to improving global health has earned it a prominent position, making it an excellent choice for investors seeking a reliable and successful pharmaceutical company.

The main competitors of Huaren Pharmaceutical Co Ltd in the market include Jiangzhong Group Co Ltd, Tasly Pharmaceutical Group Co Ltd, and Beijing Tiantan Biological Products Co Ltd.

Huaren Pharmaceutical Co Ltd is primarily active in the pharmaceutical industry.

The business model of Huaren Pharmaceutical Co Ltd focuses on the research, development, and manufacturing of pharmaceutical products. The company primarily engages in the production of traditional Chinese medicines and modern pharmaceuticals. Huaren Pharmaceutical Co Ltd actively participates in the entire value chain of the pharmaceutical industry, including drug discovery, clinical trials, production, and marketing. By emphasizing innovation and quality, the company aims to provide effective and safe healthcare solutions to its customers. Huaren Pharmaceutical Co Ltd's business model is centered on meeting the healthcare needs of individuals by offering a diverse range of high-quality pharmaceutical products.

Současně nelze vypočítat KGV pro Huaren Pharmaceutical Co.

KUV pro Huaren Pharmaceutical Co nelze v současné době vypočítat.

AlleAktien kvalitní skóre pro Huaren Pharmaceutical Co je 4/10.

Tržby pro Huaren Pharmaceutical Co nelze v současné době vypočítat.

Zisk pro Huaren Pharmaceutical Co nelze v současnosti vypočítat.

Huaren Pharmaceutical Co. Ltd is a Chinese company specializing in the manufacturing and distribution of pharmaceutical products. It was founded in 1997 and is headquartered in Xi'an, Shaanxi province, China. The company's business model focuses on producing high-quality pharmaceutical products and distributing them worldwide. It manufactures both medicines and dietary supplements, using modern production methods and strict quality control to ensure its products meet the highest standards. Huaren Pharmaceutical's core sector is the production of traditional Chinese medicines, which are made from natural plant extracts and have been an important part of Chinese medicine for centuries. The company also produces modern medicines such as antibiotics, antiviral drugs, cardiovascular medications, and diabetes medications. Another important sector for Huaren Pharmaceutical is the production of dietary supplements that support nutrition and provide essential nutrients to the body. The company also creates products tailored to the needs of children, women, and older adults. Huaren Pharmaceutical aims to develop new technologies and treatment methods to improve its customers' health and well-being. It invests a significant amount of resources in research and development, with its own laboratories and research facilities for developing new medicines and dietary supplements. As part of its growth strategy, Huaren Pharmaceutical has expanded into the export market and has exported its products to various countries worldwide. It has established distribution offices and partners in Europe, North America, and Asia to strengthen its presence in the global market. In summary, Huaren Pharmaceutical Co. Ltd specializes in manufacturing and distributing pharmaceutical products. It produces traditional Chinese medicines, modern medicines, and dietary supplements. It invests heavily in research and development, continuously improving its products and developing new technologies. By exporting its products to different countries worldwide, the company has expanded its presence in the global market.

Huaren Pharmaceutical Co vyplácí dividendu ve výši 0,02 CNY rozdělenou do výplat během roku.

Dividenda pro Huaren Pharmaceutical Co momentálně nemůže být vypočítána nebo společnost žádnou dividendu nevyplácí.

ISIN společnosti Huaren Pharmaceutical Co je CNE100000SW1.

Ticker společnosti Huaren Pharmaceutical Co je 300110.SZ.

Během posledních 12 měsíců vyplatila společnost Huaren Pharmaceutical Co dividendu ve výši 0,02 CNY . To odpovídá dividendovému výnosu přibližně 0,70 %. Pro nadcházejících 12 měsíců se očekává, že Huaren Pharmaceutical Co vyplatí dividendu ve výši 0,02 CNY.

Výnos z dividend společnosti Huaren Pharmaceutical Co aktuálně činí 0,70 %.

Huaren Pharmaceutical Co vyplácí čtvrtletní dividendu. Ta je distribuována v měsících červenec, červenec, srpen, srpen.

Huaren Pharmaceutical Co vyplácela v posledních 7 letech každý rok dividendu.

Očekává se, že v následujících 12 měsících budou dividendy ve výši 0,02 CNY. To odpovídá dividendovému výnosu 0,70 %.

Huaren Pharmaceutical Co je přiřazen k sektoru 'Zdraví'.

Aby ses mohl podílet na poslední dividendě Huaren Pharmaceutical Co ve výši 0,021 CNY, zaznamenané 10. 7. 2024, měl jsi mít akcii ve svém portfoliu před ex-dnem 10. 7. 2024.

Poslední dividendy byly vyplaceny dne 10. 7. 2024.

V roce 2023 společností Huaren Pharmaceutical Co bylo vyplaceno 0,018 CNY ve formě dividend.

Dividendy společnosti Huaren Pharmaceutical Co jsou vypláceny v CNY.